Sign in
4/A

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-17-042113

Options or other derivatives

  • Chief Technology Officer acquired 31,960 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Thornton Michael Milos · Chief Technology Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-06-09 Grant or award : show line 1 in the form Stock Options +31,960 31,960 D
Loading xslF345X03/doc4a.xml…